ELNs, Data Analytics, Knowledge Management: Trends, Challenges & Opportunities

Published on:

LONDON, May 15, 2013 -- Pharma IQ is pleased to announce the release of a brand new infographic summary of the results from an industry survey conducted earlier this year.

Building an intelligent lab informatics system is fast becoming an intrinsic part of the long term strategy for a wide range of industries, all with one common aim - to drive productivity and decision making based on improved data analysis.

As a result, the need to effectively utilize the data and apply knowledge management is being discussed in the boardroom, but how are you reacting to these changes and how will they impact the future?

To find out Pharma IQ conducted a survey and produced this one page infographic, in association with ELNs, Data Analytics and Knowledge Management Summit and is available to access free of charge from the website.

The EDKM Summit, taking place in Boston in June, is a unique event dedicated to the next generation of lab informatics applications and building a searchable, shareable database to improve decision making and efficiency.

Industry experts speaking at the event include;

Russell MacKenzie, Global Quality Analytical Services, The Coca-Cola Company; Joe Liscouski, Executive Director, Institute for Laboratory Automation; Carolyn Comenzo, Manager LIMS, Regeneron Pharmaceuticals; Mohit Agnihotri, Associate Director, IT Project Management, Novartis and B.S. Manjunath, Director, Center for Bio-image Informatics at University of California Santa Barbara to name a few.

For more information about speakers and the agenda or how to get involved, please visit: http://www.elnsandinformaticsusa.com/News or email us at enquire@iqpc.co.uk.    

About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community. Through Pharma IQ, you will be able to access pharmaceutical information resources such as presentations and podcasts, as well as events such as webinars, seminars and conferences. http://www.pharma-iq.com

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.